Tyra Biosciences Statistics
Total Valuation
TYRA has a market cap or net worth of $839.08 million. The enterprise value is $485.26 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TYRA has 52.87 million shares outstanding. The number of shares has increased by 25.11% in one year.
Current Share Class | 52.87M |
Shares Outstanding | 52.87M |
Shares Change (YoY) | +25.11% |
Shares Change (QoQ) | +0.35% |
Owned by Insiders (%) | 4.31% |
Owned by Institutions (%) | 36.56% |
Float | 22.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.32 |
P/TBV Ratio | 2.32 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.55, with a Debt / Equity ratio of 0.02.
Current Ratio | 29.55 |
Quick Ratio | 29.26 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.66% and return on invested capital (ROIC) is -20.96%.
Return on Equity (ROE) | -28.66% |
Return on Assets (ROA) | -20.21% |
Return on Capital (ROIC) | -20.96% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.71M |
Employee Count | 49 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.09% in the last 52 weeks. The beta is 1.08, so TYRA's price volatility has been similar to the market average.
Beta (5Y) | 1.08 |
52-Week Price Change | +39.09% |
50-Day Moving Average | 21.00 |
200-Day Moving Average | 19.23 |
Relative Strength Index (RSI) | 36.31 |
Average Volume (20 Days) | 616,917 |
Short Selling Information
The latest short interest is 1.76 million, so 3.32% of the outstanding shares have been sold short.
Short Interest | 1.76M |
Short Previous Month | 2.20M |
Short % of Shares Out | 3.32% |
Short % of Float | 7.66% |
Short Ratio (days to cover) | 3.68 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -100.07M |
Pretax Income | -80.88M |
Net Income | -83.74M |
EBITDA | -99.59M |
EBIT | -100.07M |
Earnings Per Share (EPS) | -$1.57 |
Full Income Statement Balance Sheet
The company has $360.13 million in cash and $6.32 million in debt, giving a net cash position of $353.81 million or $6.69 per share.
Cash & Cash Equivalents | 360.13M |
Total Debt | 6.32M |
Net Cash | 353.81M |
Net Cash Per Share | $6.69 |
Equity (Book Value) | 362.29M |
Book Value Per Share | 6.85 |
Working Capital | 353.24M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$63.72 million and capital expenditures -$1.26 million, giving a free cash flow of -$64.98 million.
Operating Cash Flow | -63.72M |
Capital Expenditures | -1.26M |
Free Cash Flow | -64.98M |
FCF Per Share | -$1.23 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |